[Macular Telangiectasia Type 2 (MacTel) - Therapeutic Options and New Developments].

Harten J, Raming K, Goerdt L, Holz F, Pfau K

Open source

DOI
10.1055/a-2936-8879
Published
2026 Sep
Container
Klinische Monatsblatter fur Augenheilkunde
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2936-8879,
  title = {[Macular Telangiectasia Type 2 (MacTel) - Therapeutic Options and New Developments].},
  author = {Harten J and Raming K and Goerdt L and Holz F and Pfau K},
  year = {2026},
  journal = {Klinische Monatsblatter fur Augenheilkunde},
  doi = {10.1055/a-2936-8879},
  url = {https://doi.org/10.1055/a-2936-8879}
}

RIS

TY  - JOUR
TI  - [Macular Telangiectasia Type 2 (MacTel) - Therapeutic Options and New Developments].
AU  - Harten J
AU  - Raming K
AU  - Goerdt L
AU  - Holz F
AU  - Pfau K
PY  - 2026
JO  - Klinische Monatsblatter fur Augenheilkunde
DO  - 10.1055/a-2936-8879
UR  - https://doi.org/10.1055/a-2936-8879
ER  - 

APA

J, H., K, R., L, G., F, H., & K, P. (2026). [Macular Telangiectasia Type 2 (MacTel) - Therapeutic Options and New Developments].. Klinische Monatsblatter fur Augenheilkunde. https://doi.org/10.1055/a-2936-8879

Source records